Reference
Saudi Food and Drug Authority (SFDA) - Safety Signal of COVID-19 Vaccine NRVV AD (CHADOX1 NCOV-19) and the Risk of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Internet Document : 3 Sep 2023. Available from: URL: https://www.sfda.gov.sa/sites/default/files/2023-09/CHADOX1-NCOV-19CIPD.pdf
Rights and permissions
About this article
Cite this article
Safety signal of CIDP with use of AstraZeneca COVID-19 vaccine. Reactions Weekly 1974, 6 (2023). https://doi.org/10.1007/s40278-023-46017-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-46017-3